Cargando...
Taking aim at Alzheimer’s disease through the mammalian target of rapamycin
A significant portion of the world’s population suffers from sporadic Alzheimer’s disease (AD) with available present therapies limited to symptomatic care that does not alter disease progression. Over the next decade, advancing age of the global population will dramatically increase the incidence o...
Gardado en:
| Publicado en: | Ann Med |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4250432/ https://ncbi.nlm.nih.gov/pubmed/25105207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/07853890.2014.941921 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|